Dr. Candace Westgate discusses the latest advancements in precision medicine and multi-cancer early detection (MCED) blood tests. This session will explain how these groundbreaking tests work, who may benefit from them, and what to consider when integrating them into a personal prevention plan. With the ability to detect dozens of cancers before symptoms arise, MCED testing represents a new frontier in proactive, individualized healthcare.

The session will begin with a 30-minute overview from Dr. Westgate, followed by a 30-minute live Q&A moderated by Dr. Lisa Larkin. Dr. Westgate will answer audience questions and address common concerns about MCED testing, cancer risk assessment, and the role of precision medicine in women’s health.

Candace Westgate, DO, FACOG, DipABLM, is a board-certified OB/GYN and Lifestyle Medicine physician specializing in preventive care and early cancer detection. She is the Medical Director of the Adventist Health AHEAD (All-Around Early Detection) Program, one of the nation’s first community-based initiatives to offer multi-cancer detection testing. Dr. Westgate is passionate about empowering patients with innovative tools to take charge of their health and catch cancer early—when it’s most treatable.

Dr. Lisa Larkin, MD, FACP, MSCP, IF, will moderate the discussion, bringing her expertise in women’s health and prevention to the conversation. As a certified menopause practitioner and founder of HERmedicine and Ms.Medicine, Dr. Larkin is dedicated to advancing evidence-based care and helping women make informed choices about their health at every stage of life.